NYSE:ELV - アナリストの将来予測と過去の財務データ ( )USD Millions
日付	収益	収益	フリー・キャッシュフロー	営業活動によるキャッシュ	平均アナリスト数
12/31/2026	195,008	9,981	9,205	10,772	7
12/31/2025	182,540	9,070	9,090	12,579	14
12/31/2024	171,655	8,056	9,763	8,467	14
3/31/2024	171,745	6,244	2,296	3,570	N/A
12/31/2023	171,340	5,987	6,765	8,061	N/A
9/30/2023	168,626	6,127	8,246	9,514	N/A
6/30/2023	165,716	6,441	10,571	11,825	N/A
3/31/2023	160,676	6,094	11,128	12,327	N/A
12/31/2022	156,599	5,894	7,247	8,399	N/A
9/30/2022	153,251	6,166	10,395	11,589	N/A
6/30/2022	149,134	6,072	8,022	9,169	N/A
3/31/2022	144,353	6,228	7,263	8,400	N/A
12/31/2021	138,643	6,158	7,277	8,364	N/A
9/30/2021	133,883	5,518	9,480	10,505	N/A
6/30/2021	129,219	4,231	5,778	6,851	N/A
3/31/2021	124,632	4,714	9,657	10,678	N/A
12/31/2020	121,868	4,572	9,667	10,688	N/A
9/30/2020	117,449	4,955	7,108	8,202	N/A
6/30/2020	112,965	5,916	9,960	11,019	N/A
3/31/2020	109,167	4,779	5,899	6,946	N/A
12/31/2019	104,212	4,807	4,984	6,061	N/A
9/30/2019	100,165	4,298	4,151	5,197	N/A
6/30/2019	96,742	4,074	3,007	4,137	N/A
3/31/2019	94,220	3,989	2,018	3,242	N/A
12/31/2018	92,091	3,750	2,619	3,827	N/A
9/30/2018	91,409	4,556	891	2,063	N/A
6/30/2018	90,584	4,344	2,825	3,861	N/A
3/31/2018	90,061	4,145	2,822	3,712	N/A
12/31/2017	90,049	3,843	N/A	4,185	N/A
9/30/2017	89,055	2,980	N/A	5,763	N/A
6/30/2017	88,038	2,851	N/A	4,322	N/A
3/31/2017	87,083	2,777	N/A	4,599	N/A
12/31/2016	84,862	2,470	N/A	3,270	N/A
9/30/2016	83,364	2,282	N/A	3,943	N/A
6/30/2016	81,866	2,319	N/A	3,322	N/A
3/31/2016	80,412	2,398	N/A	3,825	N/A
12/31/2015	79,158	2,560	N/A	4,212	N/A
9/30/2015	77,959	2,886	N/A	3,472	N/A
6/30/2015	76,605	2,862	N/A	3,734	N/A
3/31/2015	75,066	2,734	N/A	3,632	N/A
12/31/2014	73,886	2,560	N/A	3,369	N/A
9/30/2014	72,792	2,362	N/A	3,337	N/A
6/30/2014	72,090	2,385	N/A	4,129	N/A
3/31/2014	71,307	2,453	N/A	3,483	N/A
12/31/2013	71,024	2,634	N/A	3,052	N/A
9/30/2013	68,443	2,785	N/A	3,539	N/A
6/30/2013	65,941	2,823	N/A	2,382	N/A

アナリストによる今後の成長予測

収入対貯蓄率: ELVの予測収益成長率 (年間12.2% ) は貯蓄率 ( 2.4% ) を上回っています。

収益対市場: ELVの収益 ( 12.2% ) US市場 ( 14.8% ) よりも低い成長が予測されています。

高成長収益: ELVの収益は増加すると予測されていますが、大幅には増加しません。

収益対市場: ELVの収益 ( 5.1% ) US市場 ( 8.7% ) よりも低い成長が予測されています。

高い収益成長: ELVの収益 ( 5.1% ) 20%よりも低い成長が予測されています。

一株当たり利益成長率予想

将来の株主資本利益率

将来のROE: ELVの自己資本利益率は、3年後には高くなると予測されています ( 20.1 %)

Elevance Health 将来の成長

Future 基準チェック /26

主要情報

今後の成長に関する最新情報

Elevance Health, Inc. Provides Earnings Guidance for the Full Year 2024

Elevance Health, Inc. Provides Earnings Guidance for the Full Year 2024

Elevance Health, Inc. Provides Earnings Guidance for the Full Year 2023

Elevance Health, Inc. Provides Earnings Guidance for the Full Year 2023

Elevance Health Inc. Provides Earnings Guidance for the Fiscal Year 2023

Elevance Health Inc. Provides Earnings Guidance for Full Year 2022

Recent updates

Is Now An Opportune Moment To Examine Elevance Health, Inc. (NYSE:ELV)?

Upcoming dividend of US$1.63 per share

Elevance Health's (NYSE:ELV) Returns On Capital Are Heading Higher

We Think Shareholders Will Probably Be Generous With Elevance Health, Inc.'s (NYSE:ELV) CEO Compensation

Insider recently sold US$6.8m worth of stock

Elevance Health (NYSE:ELV) Has Announced A Dividend Of $1.63

Elevance Health: It's Not Too Late To Buy Their Dividend Growth

First quarter dividend of US$1.63 announced

Elevance Health, Inc. Provides Earnings Guidance for the Full Year 2024

First quarter 2024 earnings: EPS misses analyst expectations

Is Elevance Health (NYSE:ELV) Using Too Much Debt?

Elevance Health: Not Doing Enough In 2024 To Justify Premium Price

Elevance Health, Inc. to Report Q1, 2024 Results on Apr 18, 2024

StanCorp Financial Group, Inc. completed the acquisition of Life & Disability business of Elevance Health, Inc.

Elevance Health, Inc.'s (NYSE:ELV) Earnings Haven't Escaped The Attention Of Investors

Elevance: A Healthy Dose Of Dividend Growth

Insider recently sold US$1.2m worth of stock

Elevance Heath: Financial Growth And Technical Strength Indicate A Buy

Insider notifies of intention to sell stock

Upcoming dividend of US$1.63 per share

Full year 2023 earnings: EPS misses analyst expectations

Elevance Health (NYSE:ELV) Will Pay A Larger Dividend Than Last Year At $1.63

Elevance Health, Inc., Annual General Meeting, May 15, 2024

Fourth quarter dividend increased to US$1.63

Elevance Health: Time To Buy This Incredible Dividend Growth Stock

Elevance Health, Inc. Declares Quarterly Cash Dividend, Payable on March 22, 2024

Full year 2023 earnings: EPS misses analyst expectations

Elevance Health, Inc. Provides Earnings Guidance for the Full Year 2024

Slowing Rates Of Return At Elevance Health (NYSE:ELV) Leave Little Room For Excitement

Elevance Health, Inc. to Report Q4, 2023 Results on Jan 24, 2024

Elevance Health Addresses Healthcare’S Digital Divide by Increasing Access to High-Quality Smartphones and Health-Related Digital Services

Is Elevance Health (NYSE:ELV) A Risky Investment?

Elevance Health, Inc.'s (NYSE:ELV) Shares Not Telling The Full Story

Insider notifies of intention to sell stock

Upcoming dividend of US$1.48 per share at 1.2% yield

A Look At Elevance's Margin Dynamics

Is It Time To Consider Buying Elevance Health, Inc. (NYSE:ELV)?

Third quarter 2023 earnings: EPS misses analyst expectations

Elevance Health, Inc. Provides Earnings Guidance for the Full Year 2023

Elevance Health: A High Conviction Defensive Blue Chip Buy

Elevance Health, Inc. to Report Q3, 2023 Results on Oct 18, 2023

These 4 Measures Indicate That Elevance Health (NYSE:ELV) Is Using Debt Safely

Elevance: Pave The Way For The Next UnitedHealth

Elevance Health (NYSE:ELV) Is Experiencing Growth In Returns On Capital

Here's The Price I Would Buy Elevance Health Stock

Upcoming dividend of US$1.48 per share at 1.3% yield

If EPS Growth Is Important To You, Elevance Health (NYSE:ELV) Presents An Opportunity

Elevance Health, Inc. Announces Executive Changes

Is Now The Time To Look At Buying Elevance Health, Inc. (NYSE:ELV)?

Narrowing Down High-Quality Dividend Growth: Elevance Health Is Elemental

Elevance Health, Inc. Provides Earnings Guidance for the Full Year 2023

Second quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Elevance Health: Beaten Down Share Price Offers Solid Potential

Here's Why Elevance Health (NYSE:ELV) Can Manage Its Debt Responsibly

Elevance Health, Inc. to Report Q2, 2023 Results on Jul 19, 2023

Elevance Health: A Critical Update (Rating Downgrade)

Elevance Health's (NYSE:ELV) Returns On Capital Are Heading Higher

Upcoming dividend of US$1.48 per share at 1.3% yield

Is Now The Time To Look At Buying Elevance Health, Inc. (NYSE:ELV)?

First quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

We Think Elevance Health (NYSE:ELV) Can Stay On Top Of Its Debt

Upcoming dividend of US$1.48 per share at 1.3% yield

Elevance Health, Inc., Annual General Meeting, May 10, 2023

Elevance Health's (NYSE:ELV) Dividend Will Be Increased To $1.48

Elevance Health Inc. (NYSE:ELV) completed the acquisition of BioPlus Specialty Pharmacy Services, LLC from CarepathRx.

Elevance Health (NYSE:ELV) Is Experiencing Growth In Returns On Capital

Elevance Health: Attractive On Its Expansion Catalysts

Elevance Health (NYSE:ELV) Has Announced That It Will Be Increasing Its Dividend To $1.48

Full year 2022 earnings: EPS misses analyst expectations